(Q83696978)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22430888%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Effect of neoadjuvant cetuximab, capecitabine, and radiotherapy for locally advanced rectal cancer: results of a phase II study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22430888%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

1 reference

Pei-Long Sun

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22430888%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Bing Li

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22430888%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Qi-Fa Ye

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22430888%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

20 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22430888%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Colorectal Disease

26 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22430888%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22430888%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22430888%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

1325-1332

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22430888%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00384-012-1446-2

26 January 2020

exact match

0 references

cites work

Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

1 reference

12 December 2020

Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer

1 reference

12 December 2020

Neoadjuvant treatment for locally advanced rectal carcinoma

1 reference

12 December 2020

Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer

1 reference

12 December 2020

Preoperative radiotherapy of advanced rectal cancer with capecitabine and oxaliplatin with or without cetuximab: A pooled analysis of three prospective phase I-II trials

1 reference

12 December 2020

Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer.

1 reference

12 December 2020

Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer

1 reference

12 December 2020

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

1 reference

12 December 2020

Chemotherapy with preoperative radiotherapy in rectal cancer

1 reference

12 December 2020

The influence of epidermal growth factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the randomized DAHANCA 6 and 7 study.

1 reference

12 December 2020

Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status

1 reference

12 December 2020

Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: results of a Phase II MARGIT trial.

1 reference

12 December 2020

Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer

1 reference

12 December 2020

Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancer

1 reference

12 December 2020

Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer

1 reference

12 December 2020

Cancer statistics, 2006

1 reference

12 December 2020

KRAS let-7 LCS6 SNP predicts cetuximab efficacy in KRASwt metastatic colorectal cancer patients: Does treatment combination partner matter?

1 reference

12 December 2020

Estimates of cancer incidence in China for 2000 and projections for 2005.

1 reference

12 December 2020

Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer

1 reference

12 December 2020

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

1 reference

12 December 2020

Cetuximab and chemoradiation for rectal cancer--is the water getting muddy?

1 reference

12 December 2020

Preoperative treatment combining capecitabine with radiation therapy in rectal cancer: a GERCOR Phase II Study

1 reference

12 December 2020

The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multicenter, retrospective analysis

1 reference

12 December 2020

A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study

1 reference

12 December 2020

Definition and delineation of the clinical target volume for rectal cancer

1 reference

12 December 2020

Neoadjuvant treatment with single-agent cetuximab followed by 5-FU, cetuximab, and pelvic radiotherapy: a phase II study in locally advanced rectal cancer.

1 reference

12 December 2020

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

1 reference

12 December 2020

Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: a phase II study.

1 reference

12 December 2020

Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinoma

1 reference

12 December 2020

Biomarkers for Cetuximab-Based Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer

1 reference

12 December 2020

A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer

1 reference

12 December 2020

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

1 reference

12 December 2020

Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer

1 reference

12 December 2020

Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921.

1 reference

12 December 2020

Preoperative chemoradiotherapy in the management of localized rectal cancer: the new standard.

1 reference

12 December 2020

Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma

1 reference

12 December 2020